A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway

Biophysical Journal

Volumn 109, Issue 6, 2015, Pages 1214-1226

  Guven Maiorov, Emine ^a   Keskin, Ozlem ^a   Gursoy, Attila ^a   Nussinov, Ruth ^b,c  

^a KOÇ UNIVERSITY   (Turkey)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PLANT PROTEIN; TOLL LIKE RECEPTOR;

ARABIDOPSIS; CHEMISTRY; GENETICS; HUMAN; INFLAMMATION; METABOLISM; MOLECULAR MODEL; MUTATION; PARACOCCUS DENITRIFICANS; SIGNAL TRANSDUCTION;

ARABIDOPSIS; BACTERIAL PROTEINS; HUMANS; INFLAMMATION; MODELS, MOLECULAR; MUTATION; PARACOCCUS DENITRIFICANS; PLANT PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84941805448     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2015.06.048     Document Type: Article

References (75)

1. E. Guven Maiorov, and O. Keskin R. Nussinov The structural network of inflammation and cancer: merits and challenges Semin. Cancer Biol. 23 2013 243 251
2. G. Trinchieri Cancer and inflammation: an old intuition with rapidly evolving new concepts Annu. Rev. Immunol. 30 2012 677 706
3. T. Matsumura, and M. Oyama J. Inoue Identification of BCAP-(L) as a negative regulator of the TLR signaling-induced production of IL-6 and IL-10 in macrophages by tyrosine phosphoproteomics Biochem. Biophys. Res. Commun. 400 2010 265 270
4. Z.L. Chang Important aspects of Toll-like receptors, ligands and their signaling pathways Inflamm. Res. 59 2010 791 808
5. M. Ni, and A.W. MacFarlane 4th J.A. Hamerman B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K Proc. Natl. Acad. Sci. USA 109 2012 267 272
6. T.D. Troutman, and W. Hu C. Pasare Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt Proc. Natl. Acad. Sci. USA 109 2012 273 278
7. F.Y. Liew, and D. Xu L.A. O'Neill Negative regulation of toll-like receptor-mediated immune responses Nat. Rev. Immunol. 5 2005 446 458
8. J. Wang, Y. Hu, W.W. Deng, and B. Sun Negative regulation of Toll-like receptor signaling pathway Microbes Infect. 11 2009 321 327
9. J.P. Pradere, D.H. Dapito, and R.F. Schwabe The Yin and Yang of Toll-like receptors in cancer Oncogene 33 2014 3485 3495
10. Guven Maiorov, E., O. Keskin,..., R. Nussinov. 2015. The architecture of the TIR domain signalosome in the Toll-like Receptor-4 signaling pathway. Sci. Rep. 10.1038/srep13128.
11. E. Guven-Maiorov, and S.E. Acuner-Ozbabacan R. Nussinov Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy Cancers (Basel) 6 2014 663 683
12. E.S. Acuner-Ozbabacan, and B.H. Engin R. Nussinov The structural network of Interleukin-10 and its implications in inflammation and cancer BMC Genomics 15 Suppl 4 2014 S2
13. U. Ogmen, and O. Keskin A. Gursoy PRISM: protein interactions by structural matching Nucleic Acids Res. 33 2005 W331 W336
14. N. Tuncbag, and A. Gursoy O. Keskin Predicting protein-protein interactions on a proteome scale by matching evolutionary and structural similarities at interfaces using PRISM Nat. Protoc. 6 2011 1341 1354
15. A. Baspinar, and E. Cukuroglu A. Gursoy PRISM: a web server and repository for prediction of protein-protein interactions and modeling their 3D complexes Nucleic Acids Res. 42 2014 W285 W289
16. E. Mashiach, R. Nussinov, and H.J. Wolfson FiberDock: flexible induced-fit backbone refinement in molecular docking Proteins 78 2010 1503 1519
17. G. Kar, and O. Keskin A. Gursoy Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs J. Proteome Res. 11 2012 1196 1207
18. S.E. Acuner Ozbabacan, and O. Keskin A. Gursoy Enriching the human apoptosis pathway by predicting the structures of protein-protein complexes J. Struct. Biol. 179 2012 338 346
19. N. Tuncbag, and O. Keskin A. Gursoy Fast and accurate modeling of protein-protein interactions by combining template-interface-based docking with flexible refinement Proteins 80 2012 1239 1249
20. A. Roy, A. Kucukural, and Y. Zhang I-TASSER: a unified platform for automated protein structure and function prediction Nat. Protoc. 5 2010 725 738
21. E. Cerami, and J. Gao N. Schultz The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data Cancer Discov. 2 2012 401 404
22. E. Cukuroglu, A. Gursoy, and O. Keskin HotRegion: a database of predicted hot spot clusters Nucleic Acids Res. 40 2012 D829 D833
23. E. Krissinel, and K. Henrick Inference of macromolecular assemblies from crystalline state J. Mol. Biol. 372 2007 774 797
24. R. Ferrao, and J. Li H. Wu Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily Sci. Signal. 5 2012 re3
25. R. Nussinov, and H. Jang Dynamic multiprotein assemblies shape the spatial structure of cell signaling Prog. Biophys. Mol. Biol. 116 2014 158 164
26. R. Nussinov, B. Ma, and C.J. Tsai A broad view of scaffolding suggests that scaffolding proteins can actively control regulation and signaling of multienzyme complexes through allostery Biochim. Biophys. Acta 1834 2013 820 829
27. R. Nussinov, C.J. Tsai, and J. Liu Principles of allosteric interactions in cell signaling J. Am. Chem. Soc. 136 2014 17692 17701
28. D. Wald, and J. Qin X. Li SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling Nat. Immunol. 4 2003 920 927
29. E.K. Brint, and D. Xu F.Y. Liew ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance Nat. Immunol. 5 2004 373 379
30. S.H. Rhee, and H. Kim C. Pothoulakis Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells J. Biol. Chem. 281 2006 18560 18568
31. T.D. Troutman, J.F. Bazan, and C. Pasare Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K Cell Cycle 11 2012 3559 3567
32. C. Bovijn, and A.S. Desmet F. Peelman Identification of binding sites for myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 in MyD88 adapter-like (Mal) J. Biol. Chem. 288 2013 12054 12066
33. E. Aksoy, and W. Vanden Berghe F. Willems Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4 Eur. J. Immunol. 35 2005 2200 2209
34. Y. Enokizono, and H. Kumeta F. Inagaki Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling Proc. Natl. Acad. Sci. USA 110 2013 19908 19913
35. S.C. Lin, Y.C. Lo, and H. Wu Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling Nature 465 2010 885 890
36. P.G. Motshwene, and M.C. Moncrieffe N.J. Gay An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4 J. Biol. Chem. 284 2009 25404 25411
37. M. Petukh, T.G. Kucukkal, and E. Alexov On human disease-causing amino acid variants: statistical study of sequence and structural patterns Hum. Mutat. 36 2015 524 534
38. P. Allavena, and C. Garlanda A. Mantovani Pathways connecting inflammation and cancer Curr. Opin. Genet. Dev. 18 2008 3 10
39. F. Riva, and E. Bonavita C. Garlanda TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity Front. Immunol. 3 2012 322
40. J. Gong, and T. Wei S.C. Rössle Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach J. Struct. Biol. 169 2010 323 330
41. J. Qin, and Y. Qian X. Li SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms J. Biol. Chem. 280 2005 25233 25241
42. M. Lech, and V. Skuginna H.J. Anders Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis J. Pathol. 220 2010 596 607
43. C. Garlanda, H.J. Anders, and A. Mantovani TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization Trends Immunol. 30 2009 439 446
44. S.K. Drexler, and P. Kong B.M. Foxwell SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis Arthritis Rheum. 62 2010 2249 2261
45. K. Burns, and F. Martinon J. Tschopp MyD88, an adapter protein involved in interleukin-1 signaling J. Biol. Chem. 273 1998 12203 12209
46. O. Fekonja, M. Benčina, and R. Jerala Toll/interleukin-1 receptor domain dimers as the platform for activation and enhanced inhibition of Toll-like receptor signaling J. Biol. Chem. 287 2012 30993 31002
47. K. Kobayashi, and L.D. Hernandez R.A. Flavell IRAK-M is a negative regulator of Toll-like receptor signaling Cell 110 2002 191 202
48. A. Bibeau-Poirier, and M.J. Servant Roles of ubiquitination in pattern-recognition receptors and type I interferon receptor signaling Cytokine 43 2008 359 367
49. H. Nishi, A. Shaytan, and A.R. Panchenko Physicochemical mechanisms of protein regulation by phosphorylation Front. Genet. 5 2014 270
50. H. Nishi, E. Demir, and A.R. Panchenko Crosstalk between signaling pathways provided by single and multiple protein phosphorylation sites J. Mol. Biol. 427 2015 511 520
51. H. Häcker, P.H. Tseng, and M. Karin Expanding TRAF function: TRAF3 as a tri-faced immune regulator Nat. Rev. Immunol. 11 2011 457 468
52. A. Wullaert, and K. Heyninck R. Beyaert Ubiquitin: tool and target for intracellular NF-kappaB inhibitors Trends Immunol. 27 2006 533 540
53. C. Wang, and T. Chen X. Cao The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon Nat. Immunol. 10 2009 744 752
54. T.T. Lu, and M. Onizawa A. Ma Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme Immunity 38 2013 896 905
55. I.E. Wertz, and K.M. O'Rourke V.M. Dixit De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling Nature 430 2004 694 699
56. L. Catrysse, and L. Vereecke G. van Loo A20 in inflammation and autoimmunity Trends Immunol. 35 2014 22 31
57. S.C. Lin, and J.Y. Chung H. Wu Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20 J. Mol. Biol. 376 2008 526 540
58. N. Shembade, A. Ma, and E.W. Harhaj Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes Science 327 2010 1135 1139
59. S.M. Jung, and J.H. Lee S.H. Park Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6 Nat. Commun. 4 2013 2562
60. A. Ma, and B.A. Malynn A20: linking a complex regulator of ubiquitylation to immunity and human disease Nat. Rev. Immunol. 12 2012 774 785
61. S.C. Sun CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes Cell Death Differ. 17 2010 25 34
62. H. Yoshida, and H. Jono J.D. Li The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7 J. Biol. Chem. 280 2005 41111 41121
63. M.L. Seibenhener, and J.R. Babu M.W. Wooten Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation Mol. Cell. Biol. 24 2004 8055 8068
64. M.W. Wooten, and T. Geetha J. Moscat Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins J. Biol. Chem. 283 2008 6783 6789
65. K. Saito, and T. Kigawa S. Yokoyama The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma Structure 12 2004 1719 1728
66. C. Zheng, Q. Yin, and H. Wu Structural studies of NF-κB signaling Cell Res. 21 2011 183 195
67. M.W. Wooten, and M.L. Seibenhener J. Moscat The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor J. Biol. Chem. 276 2001 7709 7712
68. D.V. Veres, and D.M. Gyurkó P. Csermely ComPPI: a cellular compartment-specific database for protein-protein interaction network analysis Nucleic Acids Res. 43 2015 D485 D493
69. D. Komander, and C.J. Lord D. Barford The structure of the CYLD USP domain explains its specificity for Lys-63-linked polyubiquitin and reveals a B box module Mol. Cell 29 2008 451 464
70. N. Kayagaki, and Q. Phung V.M. Dixit DUBA: a deubiquitinase that regulates type I interferon production Science 318 2007 1628 1632
71. C.Z. Ni, and K. Welsh K.R. Ely Molecular basis for CD40 signaling mediated by TRAF3 Proc. Natl. Acad. Sci. USA 97 2000 10395 10399
72. C.Z. Ni, and G. Oganesyan K.R. Ely Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation J. Immunol. 173 2004 7394 7400
73. S. Wu, and P. Xie K.R. Ely LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3 J. Biol. Chem. 280 2005 33620 33626
74. P. Zhang, and A. Reichardt Y. Liu Single amino acid substitutions confer the antiviral activity of the TRAF3 adaptor protein onto TRAF5 Sci. Signal. 5 2012 ra81
75. Z. Isik, and T. Ersahin R. Cetin-Atalay A signal transduction score flow algorithm for cyclic cellular pathway analysis, which combines transcriptome and ChIP-seq data Mol. Biosyst. 8 2012 3224 3231